Sterility Concerns Cause Recall
Wells Pharmacy Network is voluntarily recalling all of its products due to sterility concerns.
On Sept. 20, 2016, Wells Pharmacy Network announced it was voluntarily recalling all of its sterile human and veterinary products prepared between Feb. 22, 2016 and Sept. 14, 2016 because of FDA concerns regarding a lack of sterility assurance. The company states that no adverse events have been reported as of Sept. 20, 2016.
The company is advising patients and providers to discontinue use of the recalled products and contact the company regarding the return of unused products. Adverse events in humans can be reported through FDA’s MedWatch webpage. Animal adverse events can be reported to FDA on their veterinary safety report page. The company’s press release includes a list of all recalled products.
Source: FDA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
